GlassScriptPhysician profile
Jodi Robinson
NPI 1093103152
$2,073.27
in general payments reported to CMS, 2019-2025
20 companies · $928 in 2025
The $928 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $339 · 2023: $217 · 2024: $179 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.69 |
| Education | $123.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $470.02 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $279.35 | 2024-2025 | |
| Coloplast Corp | $175.38 | 2021-2024 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $166.03 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $161.31 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $139.29 | 2021-2025 | Interstim |
| Pfizer INC. | $116.38 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $89.64 | 2025 | Trelstar |
| Tolmar, INC. | $80.45 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $66.17 | 2024-2025 | Prolaris |
| Olympus America INC. | $64.90 | 2025 | Itind System |
| Urogen Pharma, INC. | $47.73 | 2022 | |
| Janssen Biotech, INC. | $45.19 | 2021-2025 | Akeega, Erleada |
| 180 Medical, INC. | $42.45 | 2021-2022 | |
| Teleflex LLC | $26.41 | 2025 | Barrigel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $24.62 | 2023 | Provenge |
| Urovant Sciences INC | $21.94 | 2022 | |
| Axonics, INC. | $20.46 | 2024 | Axonics |
| Convatec INC. | $19.64 | 2023 | |
| Ferring Pharmaceuticals INC. | $15.91 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.